OptimizeRx Corp(OPRX) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 23 at 4:10 PM ET (Korea 9/24 05:10)
Full metrics table
| Index | - | P/E | 32.31 | EPS (ttm) | 0.24 | Insider Own | 14.99% | Shs Outstand | 18.8M | Perf Week | 0.93% |
| Market Cap | 0.14B | Forward P/E | 6.91 | EPS next Y | 20.61% | Insider Trans | - | Shs Float | 16.0M | Perf Month | -0.65% |
| Enterprise Value | 0.14B | PEG | - | EPS next Q | 0.18 | Inst Own | 68.25% | Short Float | 7.25% | Perf Quarter | 60.34% |
| Income | 0.00B | P/S | 1.45 | EPS this Y | -13.14% | Inst Trans | -10.91% | Short Ratio | 4.14 | Perf Half Y | 12.09% |
| Sales | 0.10B | P/B | 1.09 | EPS next 5Y | - | ROA | 2.76% | Short Interest | 1.16M | Perf YTD | -38.01% |
| Book/sh | 6.96 | P/C | 5.94 | EPS past 3/5Y | - | ROE | 3.68% | 52W High | -65.84% ($22.25) | Perf Year | -60.13% |
| Cash/sh | 1.28 | P/FCF | 7.69 | Sales past 3/5Y | 20.56% 20.37% | ROIC | 3.09% | 52W Low | 67.4% ($4.54) | Perf 3Y | 1.06% |
| Dividend Est. | - | EV/EBITDA | 8.89 | EPS Y/Y TTM | 145.91% | Gross Margin | 68.88% | Volatility(W/M) | 4.17% 5.07% | Perf 5Y | -90.4% |
| Dividend TTM | - | EV/Sales | 1.4 | Sales Y/Y TTM | -5.82% | Oper. Margin | 11.45% | ATR (14) | 0.4 | Perf 10Y | 134.57% |
| Dividend Ex-Date | - | Quick Ratio | 5.58 | EPS Q/Q | -146.4% | Profit Margin | 4.66% | RSI (14) | 51.7 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.58 | Sales Q/Q | -29.77% | SMA20 | -0.67% ($7.65) | Beta | 1.27 | Target Price | $12.4 |
| Payout | - | Debt/Eq | 0.15 | Earnings | 2026/8/12 | SMA50 | 4.14% ($7.3) | Rel Volume | 0.51 | Prev Close | $7.62 |
| Employees | 133 | LT Debt/Eq | 0.14 | EPS/Sales Surpr. | 44.01% 1.47% | SMA200 | -3.94% ($7.91) | Avg Volume(3M) | 0.28M | Price | $7.6 |
| IPO | 2005/5/18 | Option/Short | Yes/Yes | Trades | 2529 | Volume | 143,070 | Change | -0.26% |
Company
OPRX is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
💊 OptimizeRx is a digital healthcare technology company that connects pharmaceutical companies with medical practices. It operates a messaging platform within Electronic Health Records (EHR) and e-prescribing systems that delivers brand messages, treatment support, and out-of-pocket cost information to healthcare providers. The company focuses on enhancing the precision of pharmaceutical marketing through machine learning-based audience targeting.
Over the past 1 year, on the lower side
66% below its 1-year high.
OPRX makes money exceptionally well
11.45% of revenue is kept as operating profit.
Tap to view numbers
Growth is moderate
Earnings are expected to grow by -13.1% this year.
Tap to view numbers
The price looks about right
Trading at 32.3 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 3 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by +1.1% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 68.3%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
FDLS 0.01%
SQLV 0.00%
BTR 0.00%
FFLS 0.00%
BUYO 0.00%It ranks #4 in the industry
Based on market cap of $143M.
OPRX $143M PER 32.3
VEEV $44B PER 44.5
TEM $14B PER -
BTSG $11B PER 41.7
FAQ
What kind of company is OPRX?
OPRX belongs to the Healthcare sector and operates in the Health Information Services industry.
What is the market cap of OPRX?
The market cap of OPRX is approximately $143M, ranking 4,335 within its sector.
What is the P/E ratio of OPRX?
OPRX has a P/E ratio of approximately 32.3x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for OPRX?
OPRX has recorded a 52-week high of $22.25 and a low of $4.54.
